Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants and Procedure
2.2. Measures
2.2.1. The Near-Death-Experience Content (NDE-C) Scale
2.2.2. The Ego-Dissolution Inventory (EDI)
2.2.3. The Ego-Inflation Inventory (EII)
2.2.4. The Nature-Relatedness Scale (NR-6)
2.3. Statistics
3. Results
3.1. Demographic Data
3.2. Questionnaires
3.3. Correlations between Questionnaires
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Baumeister, R.F.; Exline, J.J. Mystical self loss: A challenge for psychological theory. Int. J. Psychol. Relig. 2002, 12, 15–20. [Google Scholar] [CrossRef]
- Dor-Ziderman, Y.; Berkovich-Ohana, A.; Glicksohn, J.; Goldstein, A. Mindfulness-induced selflessness: A MEG neurophenomenological study. Front. Hum. Neurosci. 2013, 7, 582. [Google Scholar] [CrossRef] [Green Version]
- Nour, M.M.; Evans, L.; Nutt, D.; Carhart-Harris, R.L. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Front. Hum. Neurosci. 2016, 10, 269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martial, C.; Cassol, H.; Laureys, S.; Gosseries, O. Near-death experience as a probe to explore (disconnected) consciousness. TiCS 2020, 24, 173–183. [Google Scholar] [CrossRef] [PubMed]
- Peinkhofer, C.; Dreier, J.; Kondziella, D. Semiology and mechanisms of near-death experiences. Curr. Neurol. Neurosci. Rep. 2019, 19, 9. [Google Scholar] [CrossRef]
- Charland-Verville, V.; Jourdan, J.-P.; Thonnard, M.; LeDoux, D.; Donneau, A.-F.; Quertemont, E.; Laureys, S. Near-death experiences in non-life-threatening events and coma of different etiologies. Front. Hum. Neurosci. 2014, 8, 203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martial, C.; Simon, J.; Puttaert, N.; Gosseries, O.; Charland-Verville, V.; Nyssen, A.-S.; Greyson, B.; Laureys, S.; Cassol, H. The Near-Death Experience Content (NDE-C): Development and psychometric validation. Conscious. Cogn. 2020, 86, 103049. [Google Scholar] [CrossRef] [PubMed]
- Corazza, O.; Schifano, F. Near-death states reported in a sample of 50 misusers. Subst. Use Misuse 2010, 45, 916–924. [Google Scholar] [CrossRef] [PubMed]
- Greyson, B. Incidence and correlates of near-death experiences in a cardiac care unit. Gen. Hosp. Psychiatry 2003, 25, 269–276. [Google Scholar] [CrossRef]
- Schwaninger, J.; Eisenberg, P.; Schechtman, K.; Weiss, A. A prospective analysis of near-death experiences in cardiac arrest patients. J. Near-Death Stud. 2002, 20, 215–232. [Google Scholar] [CrossRef]
- Blanke, O.; Mohr, C. Out-of-body experience, heautoscopy, and autoscopic hallucination of neurological origin. Implications for neurocognitive mechanisms of corporeal awareness and self consciousness. Brain Res. Rev. 2005, 50, 184–199. [Google Scholar] [CrossRef] [PubMed]
- Millière, R. Looking for the self: Phenomenology, neurophysiology and philosophical significance of drug-induced ego dissolution. Front. Hum. Neurosci. 2017, 11, 245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nour, M.M.; Evans, L.; Carhart-Harris, R.L. Psychedelics, personality and political perspectives. J. Psychoact. Drugs 2017, 49, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Lebedev, A.V.; Lövdén, M.; Rosenthal, G.; Feilding, A.; Nutt, D.J.; Carhart-Harris, R.L. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum. Brain Mapp. 2015, 36, 3137–3153. [Google Scholar] [CrossRef] [PubMed]
- Damasio, A. Self Comes to Mind: Constructing the Conscious. Brain; Pantheon Books: New York, NY, USA, 2010. [Google Scholar]
- Gallagher, S. Philosophical conceptions of the self: Implications for cognitive Science. TiCS 2000, 4, 14–21. [Google Scholar] [CrossRef]
- Greyson, B. Dissociation in people who have near-death experiences: Out of their bodies or out of their minds? Lancet 2000, 355, 4. [Google Scholar] [CrossRef]
- Braithwaite, J.J.; David, A.S. Out of body, out of mind? An examination of out-of-body experiences and dissociative disorders. Cogn. Neuropsychiatry 2016, 21, 373–376. [Google Scholar] [CrossRef] [PubMed]
- Sass, L.; Pienkos, E.; Nelson, B. Introspection and schizophrenia: A comparative investigation of anomalous self experiences. Conscious. Cogn. 2013, 22, 853–867. [Google Scholar] [CrossRef] [PubMed]
- Nour, M.M.; Carhart-Harris, R.L. Psychedelics and the science of self-experience. Br. J. Psychiatry 2017, 210, 177–179. [Google Scholar] [CrossRef] [Green Version]
- Griffiths, R.R.; Johnson, M.W.; Richards, W.A.; Richards, B.D.; McCann, U.; Jesse, R. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 2011, 218, 649–665. [Google Scholar] [CrossRef] [Green Version]
- Griffiths, R.R.; Richards, W.A.; Johnson, M.W.; McCann, U.D.; Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 2008, 22, 621–632. [Google Scholar] [CrossRef] [Green Version]
- Timmermann, C.; Roseman, L.; Willimans, L.; Erritzoe, D.; Martial, C.; Cassol, H.; Laureys, S.; Feilding, A.; Leech, R.; Nutt, D.; et al. DMT models the near-death experience. Front. Psychol. 2018, 9, 1424. [Google Scholar] [CrossRef] [Green Version]
- Vollenweider, F.X.; Kometer, M. The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nat. Rev. Neurosci. 2010, 11, 642–651. [Google Scholar] [CrossRef] [PubMed]
- Maqueda, A.E.; Valle, M.; Addy, P.H.; Antonijoan, R.M.; Puntes, M.; Coimbra, J.; Ballester, M.R.; Garrido, M.; González, M.; Claramunt, J.; et al. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. Int. J. Neuropsychopharmacol. 2015, 18, pyv065. [Google Scholar] [CrossRef]
- Leary, T.; Metzner, R.; Alpert, R. The Psychedelic Experience: Manual Based on the Tibetan Book of the Dead; Penguin Classics: London, UK, 1964. [Google Scholar]
- Stace, W. Mysticism and Philosophy; MacMillan Press: New York, NY, USA, 1960. [Google Scholar]
- Forstmann, M.; Sagioglou, C. Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. J. Psychopharmacol. 2017, 31, 975–988. [Google Scholar] [CrossRef] [PubMed]
- Kettner, H.; Gandy, S.; Haijen, E.C.H.M.; Carhart-Harris, R. From egoism to ecoism: Psychedelics increase nature relatedness in a state-mediated and context-dependent manner. Int. J. Environ. Res. Public Health 2019, 16, 5147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martial, C.; Cassol, H.; Charland-Verville, V.; Pallavicini, C.; Sanz, C.; Zamberlan, F.; Martínez Vivot, R.; Erowid, F.; Erowid, E.; Laureys, S.; et al. Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. Conscious. Cogn. 2019, 69, 52–69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nisbet, E.K.; Zelenski, J.M. The NR-6: A new brief measure of nature relatedness. Front. Psychol. 2013, 4, 813. [Google Scholar] [CrossRef] [Green Version]
- Bartko, J.J.; Carpenter, W.T. On the methods and theory of reliability. J. Nerv. Ment. Dis. 1976, 163, 307–317. [Google Scholar] [CrossRef] [PubMed]
- Hair, J.F.J.; Anderson, R.E.; Tatham, R.L.; Black, W.C. Multivariate Data Analysis, 5th ed.; Prentice Hall: Upper Saddle River, NJ, USA, 1998. [Google Scholar]
- Uthaug, M.V.; Lancelotta, R.; van Oorsouw, K.; Kuypers, K.P.C.; Mason, N.; Rak, J.; Šuláková, A.; Jurok, R.; Maryška, M.; Kuchař, M.; et al. single inhalation of vapor from dried toad secretion containing 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology 2019, 236, 2653–2666. [Google Scholar]
- Madsen, M.K.; Fisher, P.; Burmester, D.; Dyssegaard, A.; Stenbæk, D.; Kristiansen, S.; Johansen, S.S.; Lehel, S.; Linnet, K.; Svarer, C.; et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 2019, 44, 1328–1334. [Google Scholar] [CrossRef] [Green Version]
- Blanke, O.; Metzinger, T. Full-body illusions and minimal phenomenal selfhood. TiCS 2009, 13, 7–13. [Google Scholar] [CrossRef] [PubMed]
- Alvarado, C.S.; Zingrone, N.L. Out-of-Body Experiences among Readers of a Spanish New Age Magazine. JSPR 1999, 63, 65–85. [Google Scholar]
- Cardeña, E.; Alvarado, C.S. Anomalous self and identity experiences. In Varieties of Anomalous Experience: Examining the Scientific Evidence, 2nd ed.; Cardeña, E., Lynn, S.J., Krippner, S., Eds.; American Psychological Association: Washington, DC, USA, 2013; pp. 175–212. [Google Scholar] [CrossRef]
- Martial, C.; Cassol, H.; Charland-Verville, V.; Merckelbach, H.; Laureys, S. Fantasy proneness correlates with the intensity of near-death experience. Front. Psychiatry 2018, 9, 190. [Google Scholar] [CrossRef]
- Jansen, K. The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor. J. Near-Death Stud. 1997, 16, 5–26. [Google Scholar] [CrossRef]
- Gandy, S.; Forstmann, M.; Carhart-Harris, R.; Timmermann, C.; Luke, D.; Watts, R. The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychol. Open 2020, 7, 1–21. [Google Scholar] [CrossRef]
- Lyons, T.; Carhart-Harris, R. Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment resistant depression. J. Psychopharmacol. 2018, 32, 811–819. [Google Scholar] [CrossRef] [Green Version]
- Atwater, P.M.H. Coming Back to Life; Dodd, Mead & Co.: New York, NY, USA, 1988. [Google Scholar]
- Flynn, C. P. After the Beyond: Human Transformation and the Near-Death Experience; Prentice-Hall: Hoboken, NJ, USA, 1986. [Google Scholar]
- Groth-Marnat, G.; Summers, R. Altered beliefs, attitudes, and behaviours following near death experiences. J. Hum. Psychol. 1998, 38, 110–125. [Google Scholar] [CrossRef]
- Knoblauch, P.H.; Schmied, I.; Schnettler, B. Different Kinds of Near-Death Experience: A Report on a Survey of Near-Death Experiences in Germany. J. Near-Death Stud. 2001, 20, 15–29. [Google Scholar] [CrossRef]
- Noyes, R.; Fenwick, P.; Holden, J.M.; Christian, S.R. Aftereffects of pleasurable Western adult near-death experiences. In The Handbook of Near-Death Experiences: Thirty Years of Investigation; Holden, J.M., Greyson, B., James, D., Eds.; Praeger/ABC-CLIO: Santa Barbara, CA, USA, 2009; pp. 41–62. [Google Scholar]
- Ring, K. Life at Death: A Scientific Investigation of the Near-Death Experience; Coward, McCann & Geoghegan: NewYork, NY, USA, 1980. [Google Scholar]
- Van Lommel, P.; van Wees, R.; Meyers, V.; Elfferich, I. Near-death experience in survivors of cardiac arrest: A prospective study in the Netherlands. Lancet 2001, 358, 2039–2045. [Google Scholar] [CrossRef]
- Carhart-Harris, R.L.; Roseman, L.; Bolstridge, L.M.; Demetriou, J.N.; Pannekoek, M.B.; Wall, M.; Tanner, M.; Kaelen, J.; McGonigle, K.; Murphy, K.; et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci. Rep. 2017, 7, 13187. [Google Scholar] [CrossRef] [Green Version]
- Gasser, P.; Kirchner, K.; Passie, T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. J. Psychopharmacol. 2015, 29, 57–68. [Google Scholar] [CrossRef]
- Griffiths, R.R.; Johnson, M.W.; Carducci, M.A.; Umbricht, A.; Richards, W.; Richards, B.D.; Cosimano, M.P.; Klinedinst, M. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J. Psychopharmacol. 2016, 30, 1181–1197. [Google Scholar] [CrossRef]
- Grob, C.S.; Danforth, A.L.; Chopra, G.S.; Hagerty, M.; McKay, C.R.; Halberstadt, A.L.; Greer, G.R. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch. Gen. Psychiatry 2011, 68, 71–78. [Google Scholar] [CrossRef] [PubMed]
- Ross, S.; Bossis, A.; Guss, J.; Agin-Liebes, G.; Malone, T.; Cohen, B.; Mennenga, S.; Belser, A.; Kalliontzi, K.; Babb, J.; et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J. Psychopharmacol. 2016, 30, 1165–1180. [Google Scholar] [CrossRef] [Green Version]
- Brouwer, A.; Carhart-Harris, R.L. Pivotal mental states. J. Psychopharmacol. 2020. [Google Scholar] [CrossRef]
- Tagliazucchi, E.; Roseman, L.; Kaelen, M.; Orban, C.; Muthukumaraswamy, S.D.; Murphy, K.; Laufs, H.; Leech, R.; Mcgonigle, J.; Crossley, N.; et al. Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr. Biol. 2016, 26, 1043–1050. [Google Scholar] [CrossRef] [Green Version]
- Carhart-Harris, R.L.; Muthukumaraswamy, S.; Roseman, L.; Kaelen, M.; Droog, W.; Nutt, D.J. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc. Natl. Acad. Sci. USA 2016, 113, 4853–4858. [Google Scholar] [CrossRef] [Green Version]
- Lempert, T.; Bauer, M.; Schmidt, D. Syncope and near-death experience. Lancet 1994, 344, 829–830. [Google Scholar] [CrossRef]
- Martial, C.; Mensen, A.; Charland-Verville, V.; Vanhaudenhuyse, A.; Rentmeister, D.; Ali Bahri, M.; Cassol, H.; Englebert, J.; Gosseries, O.; Laureys, S.; et al. Neurophenomenology of near-death experience memory in hypnotic recall: A within-subject EEG study. Sci. Rep. 2019, 9, 14047. [Google Scholar] [CrossRef] [Green Version]
- Ellis, J.G.; De Koninck, J.; Bastien, C.H. Managing insomnia using lucid dreaming training: A pilot study. Behav. Sleep Med. 2021, 9, 273–283. [Google Scholar] [CrossRef]
- Campbell, J.D.; Trapnell, P.D.; Heine, S.J.; Katz, I.M.; Lavallee, L.F.; Lehman, D.R. Self-concept clarity: Measurement, personality correlates, and cultural boundaries. J. Pers. Soc. Psychol. 1996, 70, 141–156. [Google Scholar] [CrossRef]
- Carhart-Harris, R.L.; Friston, K.J. The default-mode, ego functions and free-energy: A neurobiological account of Freudian ideas. Brain 2010, 133, 1265–1283. [Google Scholar] [CrossRef]
- Ronchi, R.; Park, H.D.; Blanke, O. Bodily self-consciousness and its disorders. In Handbook of Clinical Neurology; Elsevier: Amsterdam, The Netherlands, 2018; pp. 313–330. [Google Scholar]
- Blanke, O.; Landis, T.; Spinelli, L.; Seeck, M. Out-of-body experience and autoscopy of neurological origin. Brain 2004, 127, 243–258. [Google Scholar] [CrossRef] [Green Version]
- Pfeiffer, C.; Schmutz, V.; Blanke, O. Visuospatial viewpoint manipulation during full-body illusion modulates subjective first-person perspective. Exp. Brain Res. 2014, 232, 4021–4033. [Google Scholar] [CrossRef]
- Richards, W.A. Sacred Knowledge: Psychedelics and Religious Experiences; Columbia University Press: New York, NY, USA, 2015. [Google Scholar]
Demographics | Classical NDE n = 80 | NDE-Like n = 20 | p | Effect Size |
---|---|---|---|---|
Gender—female | 47 (59%) | 14 (70%) | 0.36 | - |
Age at interview Median (IQR) | 60 (49–65) | 56 (46–61) | 0.45 | 0.109 |
Age at NDE Median (IQR) | 30 (19–43) | 26 (17–39) | 0.36 | 0.132 |
Time since NDE (year) Median (IQR) | 27 (9–38) | 26 (11–35) | 0.92 | 0.013 |
Questionnaires (Min–Max Total Score) | All NDE n = 100 | Group | p Value | Effect Size | |
---|---|---|---|---|---|
Classical NDE n = 80 | NDE-Like n = 20 | ||||
NDE-C total score (0–80) Median (IQR) | 48 (38–57) | 49 (38–59) | 47 (39–50) | 0.177 | 0.196 |
EDI (0–100) Median (IQR) | 67 (35–84) | 65 (35–82) | 69 (35–87) | 0.629 | 0.071 |
EII (0–100) Median (IQR) | 24 (3–40) | 21 (6–39) | 25 (2–41) | 0.855 | 0.027 |
NR-6 (0–5) Median (IQR) | 4 (4–5) | 4 (4–5) | 4 (4–4) | 0.716 | 0.053 |
NDE-C Scale | EDI | EII | |
---|---|---|---|
EDI | 0.55 ** (IC95 = 0.41–0.68) | ||
EII | 0.34 ** (IC95 = 0.16–0.50) | 0.23 (IC95 = 0.08–0.45) | |
NR-6 | 0.27 * (IC95 = 0.07–0.44) | 0.41 ** (IC95 = 0.23–0.56) | 0.09 (IC95 = 0.07–0.31) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Martial, C.; Fontaine, G.; Gosseries, O.; Carhart-Harris, R.; Timmermann, C.; Laureys, S.; Cassol, H. Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sci. 2021, 11, 929. https://doi.org/10.3390/brainsci11070929
Martial C, Fontaine G, Gosseries O, Carhart-Harris R, Timmermann C, Laureys S, Cassol H. Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sciences. 2021; 11(7):929. https://doi.org/10.3390/brainsci11070929
Chicago/Turabian StyleMartial, Charlotte, Géraldine Fontaine, Olivia Gosseries, Robin Carhart-Harris, Christopher Timmermann, Steven Laureys, and Héléna Cassol. 2021. "Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution" Brain Sciences 11, no. 7: 929. https://doi.org/10.3390/brainsci11070929
APA StyleMartial, C., Fontaine, G., Gosseries, O., Carhart-Harris, R., Timmermann, C., Laureys, S., & Cassol, H. (2021). Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sciences, 11(7), 929. https://doi.org/10.3390/brainsci11070929